National brain tumour research funding needs to increase to £30-35 million a year
Brain Tumour Research welcomes back furloughed colleagues
Brain Tumour Research is today welcoming back colleagues who have been furloughed during the UK coronavirus lockdown and announcing a new structure for the organisation as it continues to work with, and on behalf of, brain tumour patients and all those affected by the disease.
Announcing the changes, Chief Executive Sue Farrington Smith MBE said “hard decisions” have had to be made in order to ensure the charity is fit to tackle the challenges ahead as it continues its mission to improve patients outcomes and, ultimately, find a cure.
“We have lost more than 50% of our income over the lockdown months and, like many other charities, we have been faced with no other option but to restructure and, sadly, this has meant we have had to reduce headcount,” she said.
“We are going forward with 27 staff members compared to 38 prior to the pandemic. Whilst we have reduced the workforce by nearly 30%, we have been able to keep redundancies to a minimum through our policy of redeploying people where possible, a freeze on recruiting into vacant positions, and resignations. Sadly, and unavoidably, we have lost six valued colleagues.”
The charity also announced the appointment of Matt Smith as interim Director of Fundraising. Matt, a Consultant at THINK Consulting Solutions, has previously held positions at Marie Curie UK and WaterAid. He takes over from Robin Meltzer who leaves Brain Tumour Research to take up a senior role at the Royal Free Hospital in London.
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.